Explore the latest in rheumatoid arthritis, including recent advances in treatment of RA and in prevention of its systemic complications.
This cohort study investigates whether genomic risk for rheumatoid arthritis is associated with cognitive and psychiatric symptoms in children and adolescents.
This cross-sectional study estimates the prevalence of periodontal disease and citrullinating periodontopathic bacteria in individuals who test positive for anti–cyclic citrullinated protein (anti-CCP) antibody without rheumatoid arthritis compared with groups of healthy control participants and patients with early rheumatoid arthritis.
This study uses wholesale medication acquisition costs and Medicare claims data to assess how prices of existing tumor necrosis factor inhibitors changed in response to the market entry of new tumor necrosis factor inhibitors.
This prognostic study examines the ability of an artificial intelligence system to predict the state of disease activity in patients with rheumatoid arthritis at their next clinical visit.
This randomized clinical trial compares the effect of a magnetic resonance imaging (MRI)–guided vs a conventional clinical treat-to-remission-target strategy on improving disease activity scores and radiographic progression in patients with rheumatoid arthritis (RA) in clinical remission.
This cohort study examines the association of screening for hypogammaglobulinemia with the risk of infection and mortality in patients who received rituximab therapy.
This register-based case-control and cohort study estimates the risk of thyroxine-treated autoimmune thyroid disease among Swedish patients with rheumatoid arthritis at different time points before and after the diagnosis of rheumatoid arthritis.
This narrative review summarizes current evidence regarding the pathophysiology, diagnosis, and treatment of rheumatoid arthritis.
This study estimates mean 2017 total and out-of-pocket costs for infliximab and its biosimilar infliximab-dyyb under Medicare Part D.
A 25-year-old man with a history of rheumatoid arthritis currently taking oral methotrexate 25 mg per week presented with a lesion of the left bulbar conjunctiva of about 1 month’s duration. The lesion measured 6.5 × 2.5 mm and was firm, nonvascular, slightly mobile, and located on the superotemporal portion of the bulbar conjunctiva. What would you do next?
This national register–based study of the public health care system in Sweden assesses the risk of incident malignant neoplasms in patients with rheumatoid arthritis treated with biological disease-modifying antirheumatic drugs.
A woman in her 70s with a history of Sjogrens syndrome associated with rheumatoid arthritis complicated by Felty syndrome had progressive shortness of breath for over a decade that rapidly worsened over the course of 1 month.
This Medical News article discusses the discovery of a microbe that may trigger rheumatoid arthritis.
This Viewpoint examines the rising cost of prescription drugs using Duexis, a drug used to treat rheumatoid arthritis, osteoarthritis, and to decrease the risk of developing upper gastrointestinal ulcers, as an example.
A man in his 50s presented with a keratotic plaque with central ulceration that expressed a straw-colored fluid on the left lower leg. What is your diagnosis?
This population-based study uses data from a large health claims database to evaluate the incidence of bone fracture and characteristics that may be associated with nonunion of the fractures.
This study examines the prevalence of autoimmune diseases in patients diagnosed with lung cancer.
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: